Bio Therapeutic Drugs Company Investment Opportunity in Pune, India
Biopharma company having rights of 15 formulations looking to establish a manufacturing unit in USA.
| Established | 5-10 year(s) |
| Employees | 5 - 10 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 91 thousand |
| Run Rate Sales | USD 96 thousand |
| EBITDA Margin | 30 % |
| Industries | Bio Therapeutic Drugs |
| Locations | Pune |
| Local Time | 4:44 PM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
800 thousand
for
30.0%
stake
(Native Currency: INR 70,000,000)
Reason: We are seeking investment to start a manufacturing unit in the USA. Funds will be utilized to procur...
View More
Includes physical assets worth
USD
57 thousand
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
ROC-Verification.pdf
(73.9 KB)
Business Overview
- We are a biopharma company dealing in the research and development of various formulations and clinical trials.
- As of now the company has rights of 15 formulations and has a large market share in this industry.
- Our company has two revenue models. We treat patients majorly from the countries such as Australia, Canada, and the USA using our technology.
- These patients especially travel to India for our treatments.
- We don't have our own clinics but subcontract hospitals in Mumbai to use our technology.
- Another revenue source is to supply our formulations and technology to various other hospitals & clinics and receive a royalty from them.
- We also have discussions going on with various insurance companies to provide coverage for our treatments.
- Since the majority of our clients are from the USA we are planning to start a drug manufacturing unit there.
- This unit will be under the USFDA regulations which would increase our scope to expand into various other international markets.
- The company has two partners with a 70% and 30% stake distribution.
- Business has not taken any loans previously.
- We are seeking investment to establish the manufacturing unit.
- As of now the company has rights of 15 formulations and has a large market share in this industry.
- Our company has two revenue models. We treat patients majorly from the countries such as Australia, Canada, and the USA using our technology.
- These patients especially travel to India for our treatments.
- We don't have our own clinics but subcontract hospitals in Mumbai to use our technology.
- Another revenue source is to supply our formulations and technology to various other hospitals & clinics and receive a royalty from them.
- We also have discussions going on with various insurance companies to provide coverage for our treatments.
- Since the majority of our clients are from the USA we are planning to start a drug manufacturing unit there.
- This unit will be under the USFDA regulations which would increase our scope to expand into various other international markets.
- The company has two partners with a 70% and 30% stake distribution.
- Business has not taken any loans previously.
- We are seeking investment to establish the manufacturing unit.
Products & Services Overview
We are a biopharma company and have the intellectual property rights of 15 formulations.
Assets Overview
Physical assets include various research equipment, machines, and lab setup.Intangible assets include intellectual property rights of 15 formulations.
Facilities Overview
We have a research and development which has an area of 2,000 sq ft and is on a rental basis.
Capitalization Overview
Not Disclosed
Recent Activity
-
Earlier than 15 daysCEO, Healthcare Consulting, Koto City, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysChairman & Managing Director, Pharmaceutical Distributor, Bengaluru, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysPrincipal Consultant, Bengaluru, Financial Consultant connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
8 Investors already contacted this Business.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 62,500+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses